MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease

    A. Bertholo, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to: i) systematically evaluate literature data on acute medical management after subthalamic nucleus (STN) deep brain stimulation (DBS)  and, ii)…
  • 2019 International Congress

    Circumstances of Falls in Single and Recurrent Fallers with Parkinson’s Disease

    I. Castro, H. Cavalcanti, G. Valença, J. Filho, L. Almeida (Salvador, Brazil)

    Objective: To compare the circumstances of falls among single fallers (1 fall over one year) and recurrent fallers (≥2 falls over one year) with Parkinson´s…
  • 2019 International Congress

    Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders

    E. de Groote, K. de Keyser, A. Bockstael, D. Botteldooren, P. Santens, M. de Letter (Ghent, Belgium)

    Objective: This systematic review provides an overview of behavioral and event-related potential (ERP) studies investigating central auditory processing in patients with Parkinson’s disease (PD), progressive…
  • 2019 International Congress

    Plasma-based circulating long non-coding RNA AS-Uch1 as a novel diagnostic biomarker for Parkinson’s disease

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aimed to validate plasma-based circulating long non-coding RNA (lncRNA) as biomarker for the diagnosis of Parkinson's disease (PD). Background: Parkinson's disease (PD) is…
  • 2019 International Congress

    Synaptic dysfuncion in a Drosophila model of PARK14

    T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: To investigate the association between lipid metabolism and synaptic function in Parkinson's disease (PD) due to PLA2G6 mutations. Background: The nervous system is enriched…
  • 2019 International Congress

    Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease

    K. Kalimuthu, R. Ramachndran, A. Arulsamy, S. Savariar (Annamalainagar, India)

    Objective: The aim of this study was to examine the potential association between solvents, welding fumes and SNPs and risk of developing PD. Background: The…
  • 2019 International Congress

    The impact of HIV on the severity and course of Parkinson’s disease: a clinical case

    A. Kudrevatykh, E. Gracheva, I. Miliukhina (St. Petersburg, Russian Federation)

    Objective: About 12 million people in the world suffer from Parkinson's disease (PD), and 36.9 million suffer from HIV. The proportion of people with HIV…
  • 2019 International Congress

    Fall History and Gait Variability can Predict Falls in Individuals With Parkinson’s Disease

    L. Ma, P. Chan (Beijing, China)

    Objective: To understand the risk factors for falls in PD patients; To explore clinical indicators and Mobility Lab parameters that can predict falls in patients…
  • 2019 International Congress

    High repressive activity of olive extracts on the cell line model of Parkinson disease against ROS induction

    D. Morshedi (Tehran, Islamic Republic of Iran)

    Objective: Neurodegenerative diseases including Parkinson’s disease (PD) mostly accompany with induction of high ROS in neuronal cells. It is believed that unusual level of ROS…
  • 2019 International Congress

    Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson’s Disease and “OFF” Episodes: A Pooled Analysis

    W. Ondo, A. Ellenbogen, S. Isaacson, A. Espay, C. Singer, P. Bhargava, M. Worden, D. Blum, B. Navia (Houston, TX, USA)

    Objective: To examine safety and tolerability of apomorphine sublingual film (APL-130277; APL) during maintenance treatment using pooled data from 4 clinical studies in patients with…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley